Bioelectricty of Cancer: Voltage-Gated Ion Channels and Direct-Current Electric Fields

The Physiology of Bioelectricity in Development, Tissue Regeneration and Cancer

Volumn , Issue , 2016, Pages 267-292

  Djamgoz, Mustafa B A ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85135674942     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/b10799-17     Document Type: Chapter

References (146)

1. Abdul M and Hoosein N. 2001. Inhibition by anticonvulsants of prostate-specific antigen and interleukin-6 secretion by human prostate cancer cells. Anticancer Res 21:2045-48.
2. Abdul M and Hoosein N. 2002. Voltage-gated sodium ion channels in prostate cancer: Expression and activity. Anticancer Res 22:1727-30.
3. Abdul M and Hoosein N. 2006. Reduced Kv1.3 potassium channel expression in human prostate cancer. J Membr Biol 214:99-102.
4. Abdul S, Brown BH, Milnes P, Tidy JA. 2006. The use of electrical impedance spectroscopy in the detection of cervical intraepithelial neoplasia. Int J Gynecol Cancer 16:1823-32.
5. Abercrombie M and Ambrose EJ. 1962. The surface properties of cancer cells: A review. Cancer Res 22:525-548.
6. Adachi K, Toyota M, Sasaki Y, Yamashita T, Ishida S, Ohe-Toyota M, Maruyama R, Hinoda Y, Saito T, Imai K, Kudo R, Tokino T. 2004. Identification of SCN3B as a novel p53-inducible proapoptotic gene. Oncogene 23:7791-98.
7. Ainsworth L, Budelier K, Clinesmith M, Fiedler A, Landstrom R, et al. 2006 Transcutaneous electrical nerve stimulation (TENS) reduces chronic hyperalgesia induced by muscle inflammation. Pain 120:182-87.
8. Andrikopoulos P, Fraser SP, Patterson L, Ahmad Z, Burcu H, Ottaviani D, Diss JKJ, Box C, Eccles SA, Djamgoz MBA. 2010. Angiogenic function of voltage-gated Na+ channels in human endothelial cells: Implications for VEGF signalling. MS submitted for publication.
9. Arcangeli A, Crociani O, Lastraioli E, Masi A, Pillozzi S, Becchetti A. 2009. Targeting ion channels in cancer: A novel frontier in antineoplastic therapy. Curr Med Chem 16:66-93.
10. Ashcroft FM. 2006. From molecule to malady. Nature 440:440-47.
11. Bacac M and Stamenkovic I. 2007. Metastatic cancer cell. Annu Rev Pathol 3:221-47.
12. Bennett ES, Smith BA, Harper JM. 2004. Voltage-gated Na+ channels confer invasive properties on human prostate cancer cells. Pflugers Arch 447:908-14.
13. Berger JC, Vander-Griend D, Stadler WM, Rinker-Schaeffer C. 2004. Metastasis suppressor genes: Signal transduction, cross-talk, and the potential for modulating the behavior of metastatic cells. Anticancer Drugs 15:559-68.
14. Biran H, Ariel I, de Groot N, Shani A, Hochberg A. 1994. Human imprinted genes as oncodevelopmental markers. Tumour Biol 15:123-34.
15. Blackiston DJ, McLaughlin KA, Levin M. 2009. Bioelectric controls of cell proliferation: Ion channels, membrane voltage, and the cell cycle. Cell Cycle 8:3519-28.
16. Bolanz KA, Kovacs GG, Landowski CP, Hediger MA. 2009. Tamoxifen inhibits TRPV6 activity via estrogen receptor-independent pathways in TRPV6-expressing MCF-7 breast cancer cells. Mol Cancer Res 7:2000-10.
17. Borg JJ, Yuill KH, Hancox JC, Spencer IC, Kozlowski RZ. 2002. Inhibitory effects of the antiestrogen agent clomiphene on cardiac sarcolemmal anionic and cationic currents. J Pharmacol Exp Ther 303:282-92.
18. Brackenbury WJ, Chioni AM, Diss JKJ, Djamgoz MBA. 2007. The neonatal splice variant of Nav1.5 potentiates in vitro invasive behavior of MDA-MBA-231 human breast cancer cells. Breast Cancer Res Treat 101:149-60.
19. Brackenbury WJ and Djamgoz MBA. 2006. Activity-dependent regulation of voltagegated Na+ channel expression in Mat-LyLu rat prostate cancer cell line. J Physiol 573:343-56.
20. Brackenbury WJ and Djamgoz MBA. 2007. Nerve growth factor enhances voltage-gated Na+ channel activity and Transwell migration in Mat-LyLu rat prostate cancer cell line. J Cell Physiol 210:602-8.
21. Brackenbury WJ, Djamgoz MBA, Isom LL. 2008. An emerging role for voltage-gated Na+ channels in cellular migration: Regulation of central nervous system development and potentiation of invasive cancers. Neuroscientist 14:571-83.
22. Brown BH, Tidy JA, Boston K, Blackett AD, Smallwood RH, Sharp F. 2000. Relation between tissue structure and imposed electrical current flow in cervical neoplasia. Lancet 355:892-95.
23. Cameron IL, Smith NK, Pool TB, Sparks RL. 1980. Intracellular concentration of sodium and other elements as related to mitogenesis and oncogenesis in vivo. Cancer Res 40:1493-500.
24. Chakravarti B, Dwivedi SK, Mithal A, Chattopadhyay N. 2009. Calcium-sensing receptor in cancer: Good cop or bad cop? Endocrine 35:271-84.
25. Chang PC, Sulik GI, Soong HK, Parkinson WC. 1996. Galvanotropic and galvanotaxic responses of corneal endothelial cells. J Formos Med Assoc 95:623-27.
26. Ching CT, Sun TP, Huang SH, Hsiao CS, Chang CH, Huang SY, Chen YJ, Cheng CS, Shieh HL, Chen CY. 2010. A preliminary study of the use of bioimpedance in the screening of squamous tongue cancer. Int J Nanomed 5:213-20.
27. Chioni AM, Brackenbury WJ, Calhoun JD, Isom LL, Djamgoz MBA. 2009. A novel adhesion molecule in human breast cancer cells: Voltage-gated Na+ channel beta1 subunit. Int J Biochem Cell Biol 41:1216-27.
28. Chioni AM, Shao D, Grose R, Djamgoz MBA. 2010. Protein kinase A and regulation of neonatal Nav1.5 expression in human breast cancer cells: Activity-dependent positive feedback and cellular migration. Int J Biochem Cell Biol 42:346-58.
29. Conti M. 2007. Targeting ion channels for new strategies in cancer diagnosis and therapy. Curr Clin Pharmacol 2:135-44.
30. Cuzick J, Holland R, Barth V, Davies R, Faupel M, Fentiman I, Frischbier HJ, LaMarque JL, Merson M, Sacchini V, Vanel D, Veronesi U. 1998. Electropotential measurements as a new diagnostic modality for breast cancer. Lancet 352:359-63.
31. Ding Y, Brackenbury WJ, Onganer PU, Montano X, Porter LM, Bates LF, Djamgoz MBA. 2008. Epidermal growth factor upregulates motility of Mat-LyLu rat prostate cancer cells partially via voltage-gated Na+ channel activity. J Cell Physiol 215:77-81.
32. Diss JK, Archer SN, Hirano J, Fraser SP, Djamgoz MBA. 2001. Expression profiles of voltage-gated Na+ channel alpha-subunit genes in rat and human prostate cancer cell lines. Prostate 48:165-78.
33. Diss JK, Fraser SP, Djamgoz MBA. 2004. Voltage-gated Na+ channels: Multiplicity of expression, plasticity, functional implications and pathophysiological aspects. Eur Biophys J 33:180-93.
34. Diss JKJ, Fraser SP, Walker MM, Patel A, Latchman DS, Djamgoz MBA. 2007. Betasubunits of voltage-gated sodium channels in human prostate cancer: Quantitative in vitro and in vivo analyses of mRNA expression. Prostate Cancer Prostatic Dis 11:325-33.
35. Diss JKJ, Stewart D, Pani F, Foster CS, Walker MM, Patel A, Djamgoz MBA. 2005. A potential novel marker for human prostate cancer: Voltage-gated sodium channel expression in vivo. Prostate Cancer Prostatic Dis 8:266-73.
36. Djamgoz MBA, Mycielska M, Madeja Z, Fraser SP, Korohoda W. 2001. Directional movement of rat prostate cancer cells in direct-current electric field: Involvement of voltage-gated Na+ channel activity. J Cell Sci 114:2697-705.
37. Eccles JC and Jaeger JC. 1958. The relationship between the mode of operation and the dimensions of the junctional regions at synapses and motor end-organs. Proc R Soc Lond B Biol Sci 148:38-56.
38. Faupel M, Vanel D, Barth V, Davies R, Fentiman IS, Holland R, Lamarque JL, Sacchini V, Schreer I. 1997. Electropotential evaluation as a new technique for diagnosing breast lesions. Eur J Radiol 24:33-38.
39. Fidler IJ. 2002a. Critical determinants of metastasis. Semin Cancer Biol 12:89-96.
40. Fidler IJ. 2002b. The organ microenvironment and cancer metastasis. Differentiation 70:498-505.
41. Fidler IJ. 2003. The pathogenesis of cancer metastasis: The ‘seed and soil’ hypothesis revisited. Nat Rev Cancer 3:453-58.
42. Fiske JL, Fomin VP, Brown ML, Duncan RL, Sikes RA. 2006. Voltage-sensitive ion channels and cancer. Cancer Metastasis Rev 25:493-500.
43. Fraser SP, Ding Y, Liu A, Foster CS, Djamgoz MBA. 1999. Tetrodotoxin suppresses morphological enhancement of the metastatic Mat-LyLu rat prostate cancer cell line. Cell Tissue Res 295:505-12.
44. Fraser SP, Diss JKJ, Chioni AM, Mycielska ME, Pan H, Yamaci RF, Pani F, Siwy Z, Krakowska M, Grzywna Z, Brackenbury WJ, Theodorou D, Koyuturk M, Kaya H, Battaloğlu E, Tamburo De Bella M, Slade MJ, Tolhurst R, Palmieri C, Jiang J, Latchman DS, Coombes RC, Djamgoz MBA. 2005. Voltage-gated sodium channel expression and potentiation of human breast cancer metastasis. Clin Cancer Res 11:5381-89.
45. Fraser SP, Grimes JA, Diss JK, Stewart D, Dolly JO, Djamgoz MBA. 2003a. Predominant expression of Kv1.3 voltage-gated K+ channel subunit in rat prostate cancer cell lines: Electrophysiological, pharmacological and molecular characterisation. Pflugers Arch 446:559-71.
46. Fraser SP, Ozerlat-Gunduz I, Onkal R, Diss JK, Latchman DS, Djamgoz MBA. 2010. Estrogen and non-genomic upregulation of voltage-gated Na+ channel activity in MDAMBA-231 human breast cancer cells: Role in adhesion. J Cell Physiol 224:527-39.
47. Fraser SP and Pardo LA. 2008. Ion channels: Functional expression and therapeutic potential in cancer. Colloquium on ion channels and cancer. EMBO Rep 9:512-15.
48. Fraser SP, Salvador V, Manning EA, Mizal J, Altun S, Raza M, Berridge RJ, Djamgoz MBA. 2003b. Contribution of functional voltage-gated Na+ channel expression to cell behaviors involved in the metastatic cascade in rat prostate cancer. I. Lateral motility. J Cell Physiol 195:479-87.
49. Gallin EK. 1991. Ion channels in leukocytes. Physiol Rev 71:775-811.
50. Gillet L, Roger S, Besson P, Lecaille F, Gore J, Bougnoux P, Lalmanach G, Le Guennec JY. 2009. Voltage-gated sodium channel activity promotes cysteine cathepsin-dependent invasiveness and colony growth of human cancer cells. J Biol Chem 284:8680-91.
51. Goldenberg NM and Steinberg BE. 2010. Surface charge: A key determinant of protein localization and function. Cancer Res 70:1277-80.
52. Goldfarb M, Schoorlemmer J, Williams A, Diwakar S, Wang Q, Huang X, Giza J, Tchetchik D, Kelley K, Vega A, Matthews G, Rossi P, Ornitz DM, D’Angelo E. 2007. Fibroblast growth factor homologous factors control neuronal excitability through modulation of voltage-gated sodium channels. Neuron 55:449-63.
53. Graves CN, Sanders SS, Shoemaker RL, Rehm WS. 1975. Diffusion resistance of endothelium and stroma of bullfrog cornea determined by potential response to K+. Biochim Biophys Acta 389:550-56.
54. Grimes JA, Fraser SP, Stephens GJ, Downing JEG, Laniado ME, Foster CS, Abel PD, Djamgoz MBA. 1995. Differential expression of voltage-activated Na+ currents in two prostatic tumor cell lines: Contribution to invasiveness in vitro. FEBS Lett 369:290-94.
55. Gurel B, Iwata T, Koh CM, Yegnasubramanian S, Nelson WG, De Marzo AM. 2008. Molecular alterations in prostate cancer as diagnostic, prognostic, and therapeutic targets. Adv Anat Pathol 15:319-31.
56. Hanahan D and Weinberg RA. 2000. The hallmarks of cancer. Cell 100:57-70.
57. Herfst LJ, Rook MBA, Jongsma HJ. 2004. Trafficking and functional expression of cardiac Na+ channels. J Mol Cell Cardiol 36:185-93.
58. Hicklin DJ and Ellis LM. 2005. Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis. J Clin Oncol 23:1011-127.
59. Hille B. 1992. Ionic channels of excitable membranes. Sunderland, MA: Sinauer Associates.
60. Hoffman EP. 1995. Voltage-gated ion channelopathies: Inherited disorders caused by abnormal sodium, chloride, and calcium regulation in skeletal muscle. Annu Rev Med 46:431-41.
61. Huang CW, Cheng JY, Yen MH, Young TH. 2009. Electrotaxis of lung cancer cells in a multiple-electric-field chip. Biosens Bioelectron 24:3510-16.
62. Hunter KW. 2004. Host genetics and tumor metastasis. Br J Cancer 90:752-55.
63. Hunter KW, Crawford NP, Alsarraj J. 2008. Mechanisms of metastasis. Breast Cancer Res 10(1):S2.
64. Jarm T, Cemazar M, Steinberg F, Streffer C, Sersa G, Miklavcic D. 2003. Perturbation of blood flow as a mechanism of anti-tumor action of direct current electrotherapy. Physiol Meas 24:75-90.
65. Jefferys JG. 1995. Nonsynaptic modulation of neuronal activity in the brain: Electric currents and extracellular ions. Physiol Rev 75:689-723.
66. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ. 2008. Cancer statistics, 2008. CA Cancer J Clin 58:71-96.
67. Kai H, Suico MA, Morino S, Kondo T, Oba M, Noguchi M, Shuto T, Araki E. 2009. A novel combination of mild electrical stimulation and hyperthermia: General concepts and applications. Int J Hyperthermia 25:655-60.
68. Kim SY, Shin DH, Kim SY, Koo B-S, Bae C-D, Park J, Jeon S. 2010. Chloride channel conductance is required for NGF-induced neurite outgrowth in PC12 cells Neurochem Int 56:663-69.
69. Krasowska M, Grzywna ZJ, Mycielska ME, Djamgoz MBA. 2004. Patterning of endocytic vesicles and its control by voltage-gated Na+ channel activity in rat prostate cancer cells: Fractal analyses. Eur Biophys J 33:535-42.
70. Lang K and Bastian P. 2007. Neurotransmitter effects on tumor cells and leukocytes. Prog Exp Tumor Res 39:99-121.
71. Laniado ME, Lalani EN, Fraser SP, Grimes JA, Bhangal G, Djamgoz MBA, Abel PD. 1997. Expression and functional analysis of voltage-activated Na+ channels in human prostate cancer cell lines and their contribution to invasion in vitro. Am J Pathol 150:1213-21.
72. Le Guennec JY, Ouadid-Ahidouch H, Soriani O, Besson P, Ahidouch A, Vandier C. 2007. Voltage-gated ion channels, new targets in anti-cancer research. Recent Pat Anticancer Drug Discov 2:189-202.
73. Leung SW, Teoh H, Keung W, Man RY. 2007. Non-genomic vascular actions of female sex hormones: Physiological implications and signalling pathways. Clin Exp Pharmacol Physiol 34:822-26.
74. Li X and Kolega J. 2002. Effects of direct current electric fields on cell migration and actin filament distribution in bovine vascular endothelial cells. J Vasc Res 39:391-404.
75. Lin F, Baldessari F, Gyenge CC, Sato T, Chambers RD, Santiago JG, Butcher EC. 2008. Lymphocyte electrotaxis in vitro and in vivo. J Immunol 181:2465-71.
76. Liu H, Wu MM, Zakon HH. 2008. A novel Na+ channel splice form contributes to the regulation of an androgen-dependent social signal. J Neurosci 28:9173-82.
77. Mahaut-Smith MP, Martinez-Pinna J, Gurung IS. 2008. A role for membrane potential in regulating GPCRs? Trends Pharmacol Sci 29:421-29.
78. Marban E. 2002. Cardiac channelopathies. Nature 415:213-18.
79. McCaig CD, Song B, Rajniek AM. 2009. Electric dimensions in cell science. J Cell Sci 122:4267-76.
80. McLaughlin S and Poo MM. 1981. The role of electro-osmosis in the electric-field-induced movement of charged macromolecules on the surfaces of cells. Biophys J 34:85-93.
81. Meisler MH, Kearney JA, Sprunger LK, MacDonald BT, Buchner DA, Escayg A. 2002. Mutations of voltage-gated sodium channels in movement disorders and epilepsy. Novart Fdn Symp 241:72-86.
82. Miklavcic D, Jarm T, Cemazar M, Sersa G, An DJ. Belehradek J, Mir LM. 1997. Tumor treatment by direct electric current. Tumor perfusion changes. Bioelectrochem Bioenerg 43:253-56.
83. Mobbs RJ, Nair S, Blum P. 2007. Peripheral nerve stimulation for the treatment of chronic pain. J Clin Neurosci 14:216-21.
84. Monk M and Holding C. 2001. Human embryonic genes re-expressed in cancer cells. Oncogene 20:8085-91.
85. Mycielska ME and Djamgoz MBA. 2004. Cellular mechanisms of direct-current electric field effects: Galvanotaxis and metastatic disease. J Cell Sci 117:1631-39.
86. Mycielska ME, Fraser SP, Szatkowski M, Djamgoz MBA. 2003. Contribution of functional voltage-gated Na+ channel expression to cell behaviors involved in the metastatic cascade in rat prostate cancer. II. Secretory membrane activity. J Cell Physiol 195:461-69.
87. Mycielska ME, Palmer CP, Brackenbury WJ, Djamgoz MBA. 2005. Expression of Na+-dependent citrate transport in a strongly metastatic human prostate cancer PC-3M cell line: Regulation by voltage-gated Na+ channel activity. J Physiol 563:393-408.
88. Mycielska ME, Patel A, Rizaner N, Mazurek MP, Keun H, Patel A, Ganapathy V, Djamgoz MBA. 2009. Citrate transport and metabolism in mammalian cells: Prostate epithelial cells and prostate cancer. BioEssays 31:10-20.
89. Nakajima T, Kubota N, Tsutsumi T, Oguri A, Imuta H, Jo T, Oonuma H, Soma M, Meguro K, Takano H, Nagase T, Nagata T. 2009. Eicosapentaenoic acid inhibits voltagegated sodium channels and invasiveness in prostate cancer cells. Br J Pharmacol 56:420-31.
90. Near J, Romagnoli C, Curtis AT, Klassen LM, Izawa J, Chin J, Bartha R. 2009. High-field MRSI of the prostate using a transmit/receive endorectal coil and gradient modulated adiabatic localization. J Magn Reson Imaging 30:335-43.
91. Nelson FR, Brighton CT, Ryaby J, Simon BJ, Nielson JH, et al. 2003. Use of physical forces in bone healing. J Am Acad Orthop Surg 11:344-54.
92. Nguyen DX and Massague J. 2007. Genetic determinants of cancer metastasis. Nat Rev Genet 8:341-52.
93. Nicolson GL. 1976. Trans-membrane control of the receptors on normal and tumor cells. II. Surface changes associated with transformation and malignancy. Biochim Biophys Acta 458:1-72.
94. Nzula S, Going JJ, Stott DI. 2003. Antigen-driven clonal proliferation, somatic hypermutation, and selection of B lymphocytes infiltrating human ductal breast carcinomas. Cancer Res 63:3275-80.
95. Onganer PU and Djamgoz MBA. 2005. Small-cell lung cancer (human): Potentiation of endocytic membrane activity by voltage-gated Na+ channel expression in vitro. J Membr Biol 204:67-75.
96. Onkal R and Djamgoz MBA. 2009. Molecular pharmacology of voltage-gated sodium channel expression in metastatic disease: Clinical potential of neonatal Nav1.5 in breast cancer. Eur J Pharmacol 625:206-19.
97. Ouwerkerk R, Jacobs MA, Macura KJ, Wolff AC, Stearns V, Mezban SD, Khouri NF, Bluemke DA, Bottomley PA. 2007. Elevated tissue sodium concentration in malignant breast lesions detected with non-invasive (23)Na MRI. Breast Cancer Res Treat 106:151-60.
98. Palmer CP, Mycielska ME, Burcu H, Osman K, Collins T, Beckerman R, Perrett R, Johnson H, Aydar E, Djamgoz MBA. 2008. Single cell adhesion measuring apparatus (SCAMA): Application to cancer cell lines of different metastatic potential and voltage-gated Na+ channel expression. Eur Biophys J 37:359-68.
99. Prevarskaya N, Skryma R, Bidaux G, Flourakis M, Shuba Y. 2007. Ion channels in death and differentiation of prostate cancer cells. Cell Death Differ 14:1295-304.
100. Prevarskaya N, Skryma R, Shuba Y. 2010. Ion channels and the hallmarks of cancer. Trends Mol Med 16:107-21.
101. Prossnitz ER, Arterburn JB, Smith HO, Oprea TI, Sklar LA, Hathaway HJ. 2008. Estrogen signaling through the transmembrane G protein-coupled receptor GPR30. Annu Rev Physiol 70:165-90.
102. Pu J, McCaig CD, Cao L, Zhao Z, Segall JE, Zhao M. 2007. EGF receptor signalling is essential for electric-field-directed migration of breast cancer cells. J Cell Sci 120:3395-403.
103. Ramirez ML, Nelson EC, Evans CP. 2008. Beyond prostate-specific antigen: Alternate serum markers. Prostate Cancer Prostatic Dis 11:216-29.
104. Revest, PA, Jones HC, Abbott NJ. 1993. The transendothelial DC potential of rat bloodbrain barrier vessels in situ. Adv Exp Med Biol 331:71-74.
105. Revest PA, Jones HC, Abbott NJ. 1994. Transendothelial electrical potential across pial vessels in anaesthetised rats: A study of ion permeability and transport at the bloodbrain barrier. Brain Res 652:76-82.
106. Roberts R and Brugada R. 2003. Genetics and arrhythmias. Annu Rev Med 54:257-67.
107. Roger S, Besson P, Le Guennec JY. 2003. Involvement of a novel fast inward sodium current in the invasion capacity of a breast cancer cell line. Biochim Biophys Acta 1616:107-11.
108. Roger S, Potier M, Vandier C, Besson P, Le Guennec JY. 2006. Voltage-gated sodium channels: New targets in cancer therapy? Curr Pharm Des 12:3681-95.
109. Roger S, Rollin J, Barascu A, Besson P, Raynal PI, Iochmann S, Lei M, Bougnoux P, Gruel Y, Le Guennec JY. 2007. Voltage-gated sodium channels potentiate the invasive capacities of human non-small-cell lung cancer cell lines. Int J Biochem Cell Biol 39:774-86.
110. Rose CR, Blum R, Kafitz KW, Kovalchuk Y, Konnerth A. 2004. From modulator to mediator: Rapid effects of BDNF on ion channels. BioEssays 26:1185-94.
111. Saidak Z, Mentaverri R, Brown EM. 2009. The role of the calcium-sensing receptor in the development and progression of cancer. Endocr Rev 30:178-95.
112. Santen RJ, Song RX, Masamura S, Yue W, Fan P, Sogon T, Hayashi S, Nakachi K, Eguchi H. 2008. Adaptation to estradiol deprivation causes up-regulation of growth factor pathways and hypersensitivity to estradiol in breast cancer cells. Adv Exp Med Biol 630:19-34.
113. Santen RJ, Song RX, Zhang Z, Kumar R, Jeng MH, Masamura A, Lawrence J Jr, Berstein L, Yue W. 2005. Long-term estradiol deprivation in breast cancer cells up-regulates growth factor signaling and enhances estrogen sensitivity. Endocr Relat Cancer 12:S61-73.
114. Schepkin VD, Chenevert TL, Kuszpit K, Lee KC, Meyer CR, Johnson TD, Rehemtulla A, Ross BD. 2006a. Sodium and proton diffusion MRI as biomarkers for early therapeutic response in subcutaneous tumors. Magn Reson Imaging 24:273-78.
115. Schepkin VD, Lee KC, Kuszpit K, Muthuswami M, Johnson TD, Chenevert TL, Rehemtulla A, Ross BD. 2006b. Proton and sodium MRI assessment of emerging tumor chemotherapeutic resistance. NMR Biomed 19:1035-42.
116. Schuller HM. 2008. Neurotransmission and cancer: Implications for prevention and therapy. Anticancer Drugs 19:655-71.
117. Schwirzke M, Schiemann S, Gnirke AU, Weidle UH. 1999. New genes potentially involved in breast cancer metastasis. Anticancer Res 19:1801-14.
118. Shao D, Okuse K, Djamgoz MBA. 2009. Protein-protein interactions involving voltagegated sodium channels: Post-translational regulation, intracellular trafficking and functional expression. Int J Biochem Cell Biol 41:1471-81.
119. Sikes RA, Walls AM, Brennen WN, Anderson JD, Choudhury-Mukherjee I, Schenck HA, Brown ML. 2003. Therapeutic approaches targeting prostate cancer progression using novel voltage-gated ion channel blockers. Clin Prostate Cancer 2:181-87.
120. Sisman AR, Sis B, Canda T, Onvural B. 2009. Electrolytes and trace elements in human breast cyst fluid. Biol Trace Elem Res 128:18-30.
121. Smith NR, Sparks RL, Pool TB, Cameron IL. 1978. Differences in the intracellular concentration of elements in normal and cancerous liver cells as determined by x-ray microanalysis. Cancer Res 38:1952-59.
122. Smith P, Rhodes NP, Shortland AP, Fraser SP, Djamgoz MBA, Ke Y, Foster CS. 1998. Sodium channel protein expression enhances the invasiveness of rat and human prostate cancer cells. FEBS Lett 423:19-24.
123. Somjen GG. 2001. Mechanisms of spreading depression and hypoxic spreading depression-like depolarization. Physiol Rev 81:1065-96.
124. Sylantyev S, Savtchenko LP, Niu YP, Ivanov AI, Jensen TP, Kullmann DM, Xiao MY, Rusakov DA. 2008. Electric fields due to synaptic currents sharpen excitatory transmission. Science 319:1845-49.
125. Szatkowski M, Mycielska M, Knowles R, Kho A-L, Djamgoz MBA. 2000. Electrophysiological recordings from the rat prostate gland in vitro. Identified single cell and trans-epithelial (lumen) potentials. BJU Int 86:1-8.
126. Takebe N and Ivy SP. 2010. Controversies in cancer stem cells: Targeting embryonic signaling pathways. Clin Cancer Res 16:3106-12.
127. Toledo-Aral JJ, Brehm P, Halegoua S, Mandel G. 1995. A single pulse of nerve growth factor triggers long-term neuronal excitability through sodium channel gene induction. Neuron 14:607-11.
128. Tsang SY, Yao XQ, Wong CM, Chan FL, Chen ZY, Huang Y. 2004. Differential regulation of K+ and Ca2+ channel gene expression by chronic treatment with estrogen and tamoxifen in rat aorta. Eur J Pharmacol 483:155-62.
129. Tse GM, Tan PH, Pang AL, Tang AP, Cheung HS. 2008. Calcification in breast lesions: Pathologists’ perspective. J Clin Pathol 61:145-51.
130. Uysal-Onganer P and Djamgoz MBA. 2007. Epidermal growth factor potentiates in vitro metastatic behavior of human prostate cancer PC-3M cells: Involvement of voltagegated sodium channel. Mol Cancer 6:76.
131. Vaidya KS and Welch DR. 2007. Metastasis suppressors and their roles in breast carcinoma. J Mammary Gland Biol Neoplasia 12:175-90.
132. Ventura AC and Merajver SD. 2008. Genetic determinants of aggressive breast cancer. Annu Rev Med 59:199-212.
133. Vogl TJ, Mayer HP, Zangos S, Selby JB Jr, Ackermann H, Mayer FB. 2007. Prostate cancer: MR imaging-guided galvanotherapy-Technical development and first clinical results. Radiology 245:895-902.
134. Waxman SG. 2001. Acquired channelopathies in nerve injury and MS. Neurology 56:1621-27.
135. Waxman SG. 2007. Channel, neuronal and clinical function in sodium channelopathies: From genotype to phenotype. Nat Neurosci 10:405-9.
136. Weigelt B, Hu Z, He X, Livasy C, Carey LA, Ewend MG, Glas AM, Perou CM, Van’t Veer LJ. 2005. Molecular portraits and 70-gene prognosis signature are preserved throughout the metastatic process of breast cancer. Cancer Res 65:9155-58.
137. Welch DR. 2004. Microarrays bring new insights into understanding of breast cancer metastasis to bone. Breast Cancer Res 6:61-64.
138. Welch DR. 2006. Do we need to redefine a cancer metastasis and staging definitions? Breast Dis 26:3-12.
139. Welch DR, Steeg PS, Rinker-Schaeffer CW. 2000. Molecular biology of breast cancer metastasis. Genetic regulation of human breast carcinoma metastasis. Breast Cancer Res 2:408-16.
140. Wepsic HT. 1983. Overview of oncofetal antigens in cancer. Ann Clin Lab Sci 13:261-66.
141. Williams EL and Djamgoz MBA. 2005. Nitric oxide and metastatic cell behavior. BioEssays 27:1228-38.
142. Wyckoff JB, Jones JG, Condeelis JC, Segall JE. 2000. A critical step in metastasis: In vivo analysis of intravasation at the primary tumor. Cancer Res 60:2504-11.
143. Xin YL. 1994. Advances in the treatment of malignant tumors by electrochemical therapy (ECT). Eur J Surg Suppl 574:31-35.
144. Zhang C, Bosch MA, Rick EA, Kelly MJ, Rønnekleiv OK. 2009. 17Beta-estradiol regulation of T-type calcium channels in gonadotropin-releasing hormone neurons. J Neurosci 29:10552-62.
145. Zhao M, Bai H, Wang E, Forrester JV, McCaig CD. 2004. Electrical stimulation directly induces pre-angiogenic responses in vascular endothelial cells by signalling through VEGF receptors. J Cell Sci 117:397-405.
146. Zsiros E, Kis-Toth K, Hajdu P, Gaspar R, Bielanska J, Felipe A, Rajnavolgyi E, Panyi G. 2009. Developmental switch of the expression of ion channels in human dendritic cells. J Immunol 183:4483-92.